Breast Cancer — Year in Review Series on Relevant New Datasets and Advances

Research To Practice | Oncology Videos · May 7, 2025 · 59m

Featuring perspectives from Prof Rebecca A Dent and Dr Nancy U Lin, including the following topics:

Introduction: A New Paradigm for Triple-Positive Breast Cancer? (0:00)

CDK4/6 Inhibitors for HR-Positive, HER2-Negative Breast Cancer (10:06)

Oral Selective Estrogen Receptor Degraders for HR-Positive, HER2-Negative Breast Cancer (21:17)

Treatment of PIK3CA/PTEN/AKT-Mutated Breast Cancer (31:34)

Antibody-Drug Conjugates (ADCs) for HR-Positive, HER2-Negative Breast Cancer (38:41)

ADCs for HER2-Positive Breast Cancer (46:30)

HER2-Targeting Tyrosine Kinase Inhibitors for HER2-Positive Breast…